Posted: December 9, 2014

A gynecological tool called a power morcellator has been found to spread cancer during routine laparoscopic hysterectomies and myomectomies, or fibroid tumor removal.

The morcellator cuts through uterine tissue to allow it to be easily removed through a small incision in the abdomen. During this procedure, however, previously undetected cancer cells, specifically uterine sarcomas, can be spread throughout the abdomen and pelvic area. 

While the U.S. Food and Drug Administration (FDA) recently issued a warning concerning the possible spread of cancer from the use of morcellators, the devices are still on the market. In fact, many gynecologists continue to use the device for laparoscopic hysterectomies and myomectomies. 

If you underwent a laparoscopic hysterectomy or myomectomy using a power morcellator and were later diagnosed with uterine cancer, you may be entitled to compensation from one of the device manufacturers. Contact one of our experienced attorneys for a free case evaluation. Call us at 800-243-1100 or click here to learn more.